top of page
3 to 5 February, 2027⎮Advancing Gene Therapies & Enabling Disease Models
A joint conference of the GET-IN & LifeLUNG EU consortia



Omniscope Wins AI Discovery Award: Strengthening LifeLUNG’s Mission to Decode Transplant Immunology
We are delighted to celebrate an exciting achievement from our LifeLUNG partner, Omniscope, which has been awarded the Nebius AI Discovery Award in Genomics. This recognition highlights Omniscope’s pioneering work at the intersection of artificial intelligence, genomics, and immunology. As Omniscope states: “Decoding the immune system is very hard and has not yet been achieved. However, once fully decoded and once we can see what the immune system sees, we have the keys to un
Jul 2


🎤 Great presentation from our LifeLUNG supervisors! REGMED XB
We are proud to see Rik Gijsbers and Marianne Carlon (KU Leuven) deliver a keynote at the RegMed XB 4th Annual Conference in Utrecht, showcasing LifeLUNG's vision and progress. Their presentation covered the full spectrum, from cutting-edge gene therapy vectors and living lung disease models to a clear-eyed roadmap for clinical translation. It was a masterclass in how to build not just a therapy, but an entire ecosystem around it. Thank you both for representing LifeLUNG so
Jun 19


🫁 A lung. Alive. Outside the body.
🫁 A lung. Alive. Outside the body. This is made possible by Ex Vivo Lung Perfusion (EVLP), a technology that keeps donor lungs warm, ventilated, and functioning outside the body before transplantation. Using EVLP, clinicians can assess, preserve, and even treat donor lungs before they are transplanted into a patient. At LifeLUNG, we're taking that technology further. In our ongoing research, we are developing EVLP into a more advanced treatment platform, with two specific go
Jun 19
bottom of page
